Package | ans.fhir.fr.eclaire |
Type | ConceptMap |
Id | Id |
FHIR Version | R4 |
Source | https://interop.esante.gouv.fr/ig/fhir/eclaire/https://interop.esante.gouv.fr/ig/fhir/eclaire/0.3.0/ConceptMap-eclaire-study-phase-concept-map.html |
Url | https://interop.esante.gouv.fr/ig/fhir/eclaire/ConceptMap/eclaire-study-phase-concept-map |
Version | 0.3.0 |
Status | draft |
Date | 2024-02-26T13:32:37+00:00 |
Name | FHIR_Eclaire_phase_concept_map |
Title | FHIR/Eclaire ResearchStudy phase Use Mapping |
Experimental | True |
Realm | fr |
Authority | national |
Description | Correspondance entre la phase définie dans la base Eclaire et le ValueSet https://interop.esante.gouv.fr/ig/fhir/eclaire/ValueSet-eclaire-study-phase-vs |
No resources found
CodeSystem | |
http://terminology.hl7.org/CodeSystem/research-study-phase ![]() | ResearchStudyPhase |
http://terminology.hl7.org/CodeSystem/research-study-phase ![]() | ResearchStudyPhase |
Note: links and images are rebased to the (stated) source
Mapping from Value Set de la phase de l'essai tel que définie dans la base ECLAIRE to Value Set type de phase de l'essai clinique
DRAFT (not intended for production usage). Published on 2024-02-26 13:32:37+0000 by ANS (ANS: https://esante.gouv.fr).
Correspondance entre la phase définie dans la base Eclaire et le ValueSet https://interop.esante.gouv.fr/ig/fhir/eclaire/ValueSet-eclaire-study-phase-vs
Group 1Mapping from Définition des phase de l'essai utilisés dans la base de données ECLAIRE to ResearchStudyPhase
Group 2Mapping from Définition des phase de l'essai utilisés dans la base de données ECLAIRE to Définition des type de phase de l'essai cliniques incluant https://hl7.org/fhir/R4/valueset-research-study-phase.html
Source Code | Relationship | Target Code |
phase-III-IV (Phase III and phase IV (Integrated)) | phase-3-phase-4 (Phase 3 and phase 4) |
{
"resourceType" : "ConceptMap",
"id" : "eclaire-study-phase-concept-map",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Mapping from <a href=\"ValueSet-eclaire-study-phase-source-vs.html\">Value Set de la phase de l'essai tel que définie dans la base ECLAIRE</a> to <a href=\"ValueSet-eclaire-study-phase-vs.html\">Value Set type de phase de l'essai clinique</a></p><p>DRAFT (not intended for production usage). Published on 2024-02-26 13:32:37+0000 by ANS (ANS: <a href=\"https://esante.gouv.fr\">https://esante.gouv.fr</a>). </p><div><p>Correspondance entre la phase définie dans la base Eclaire et le ValueSet https://interop.esante.gouv.fr/ig/fhir/eclaire/ValueSet-eclaire-study-phase-vs</p>\n</div><br/><p><b>Group 1</b>Mapping from <a href=\"CodeSystem-eclaire-study-phase-source-code-system.html\">Définition des phase de l'essai utilisés dans la base de données ECLAIRE</a> to <a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-research-study-phase.html\">ResearchStudyPhase</a></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td></tr><tr><td>jarde-early (Jardé phase précoce)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1</td></tr><tr><td>jarde-early (Jardé phase précoce)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-I-first-admin (Human Pharmacology (Phase I) - First administration to humans)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1</td></tr><tr><td>phase-I-bioequivalence (Human Pharmacology (Phase I) - Bioequivalence Study)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1</td></tr><tr><td>phase-I-other (Human Pharmacology (Phase I) - Other)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1</td></tr><tr><td>phase-I-II-first-admin (Phase I and Phase II (Integrated) - First administration to humans)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-I-II-first-bioequivalence (Phase I and Phase II (Integrated) - Bioequivalence Study)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-I-II-other (Phase I and Phase II (Integrated) - Other)</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-1-phase-2 (Phase 1/Phase 2)</td></tr><tr><td>phase-II (Therapeutic exploratory (Phase II))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-2</td></tr><tr><td>phase-II-III (Phase II and Phase III (Integrated))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-2-phase-3 (Phase 2/Phase 3)</td></tr><tr><td>phase-III (Therapeutic confirmatory (Phase III))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-3</td></tr></table><hr/><p><b>Group 2</b>Mapping from <a href=\"CodeSystem-eclaire-study-phase-source-code-system.html\">Définition des phase de l'essai utilisés dans la base de données ECLAIRE</a> to <a href=\"CodeSystem-eclaire-study-phase-code-system.html\">Définition des type de phase de l'essai cliniques incluant https://hl7.org/fhir/R4/valueset-research-study-phase.html</a></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td></tr><tr><td>phase-III-IV (Phase III and phase IV (Integrated))</td><td><a href=\"http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#null\"/></td><td>phase-3-phase-4 (Phase 3 and phase 4)</td></tr></table></div>"
},
"url" : "https://interop.esante.gouv.fr/ig/fhir/eclaire/ConceptMap/eclaire-study-phase-concept-map",
"version" : "0.3.0",
"name" : "FHIR_Eclaire_phase_concept_map",
"title" : "FHIR/Eclaire ResearchStudy phase Use Mapping",
"status" : "draft",
"experimental" : true,
"date" : "2024-02-26T13:32:37+00:00",
"publisher" : "ANS",
"contact" : [
{
"name" : "ANS",
"telecom" : [
{
"system" : "url",
"value" : "https://esante.gouv.fr"
}
]
}
],
"description" : "Correspondance entre la phase définie dans la base Eclaire et le ValueSet https://interop.esante.gouv.fr/ig/fhir/eclaire/ValueSet-eclaire-study-phase-vs",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "FR",
"display" : "FRANCE"
}
]
}
],
"sourceUri" : "eclaire-study-phase-source-vs",
"targetUri" : "eclaire-study-phase-vs",
"group" : [
{
"source" : "eclaire-study-phase-source-code-system",
"target" : "http://terminology.hl7.org/CodeSystem/research-study-phase",
"element" : [
{
"code" : "jarde-early",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "equivalent"
}
],
"code" : "phase-1",
"equivalence" : "equivalent"
}
]
},
{
"code" : "jarde-early",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "equivalent"
}
],
"code" : "phase-1-phase-2",
"equivalence" : "equivalent"
}
]
},
{
"code" : "phase-I-first-admin",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "wider"
}
],
"code" : "phase-1",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-bioequivalence",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "wider"
}
],
"code" : "phase-1",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-other",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "wider"
}
],
"code" : "phase-1",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-II-first-admin",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "wider"
}
],
"code" : "phase-1-phase-2",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-II-first-bioequivalence",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "wider"
}
],
"code" : "phase-1-phase-2",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-I-II-other",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "wider"
}
],
"code" : "phase-1-phase-2",
"equivalence" : "wider"
}
]
},
{
"code" : "phase-II",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "equivalent"
}
],
"code" : "phase-2",
"equivalence" : "equivalent"
}
]
},
{
"code" : "phase-II-III",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "equivalent"
}
],
"code" : "phase-2-phase-3",
"equivalence" : "equivalent"
}
]
},
{
"code" : "phase-III",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "equivalent"
}
],
"code" : "phase-3",
"equivalence" : "equivalent"
}
]
}
]
},
{
"source" : "eclaire-study-phase-source-code-system",
"target" : "eclaire-study-phase-code-system",
"element" : [
{
"code" : "phase-III-IV",
"target" : [
{
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/1.0/StructureDefinition/extension-ConceptMap.element.target.equivalence",
"valueCode" : "equivalent"
}
],
"code" : "phase-3-phase-4",
"equivalence" : "equivalent"
}
]
}
]
}
]
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.